Cargando…

Bisphosphonates for Prevention of Bone Loss in Glucocorticoid-Treated Young People

Detalles Bibliográficos
Autor principal:	Reid, Ian R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686132/ https://www.ncbi.nlm.nih.gov/pubmed/31414078 http://dx.doi.org/10.1016/j.eclinm.2019.07.002

Ejemplares similares

Treating self-harm in young people
por: Borschmann, Rohan, et al.
Publicado: (2020)

Differences between the bisphosphonates for the prevention and treatment of osteoporosis
por: Grey, Andrew, et al.
Publicado: (2006)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

Eliminating the need for fasting with oral administration of bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2013)

Bisphosphonates and direct fracture healing: Area to be explored
por: Goyal, Tarun, et al.
Publicado: (2014)

Extensive Osteonecrosis After Glucocorticoids: Clinical Response to Bisphosphonate
por: Subbu, Karthik, et al.
Publicado: (2022)

Use of bisphosphonates in advanced prostate cancer: Current status
por: Lilleby, Wolfgang
Publicado: (2007)

Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988)

Bone Sparing Effects of Bisphosphonates in Cyclosporine-induced Alveolar Bone Loss: An Animal Study
por: Bhat, Sneha R, et al.
Publicado: (2020)

Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Hu, Yan, et al.
Publicado: (2017)

Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice
por: Krüger, Benjamin Thilo, et al.
Publicado: (2022)

Should all adjuvant breast cancer patients receive a bisphosphonate?
por: Cameron, David A
Publicado: (2003)

Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients
por: Cho, Soo-Kyung, et al.
Publicado: (2021)

Young People’s Mental Health
por: Wyn, Johanna
Publicado: (2022)

Glucocorticoids and “Stress” Are Not Synonymous
por: MacDougall-Shackleton, S A, et al.
Publicado: (2019)

Long term bisphosphonate therapy & atypical femoral fractures: A word of caution
por: Reddy, Sagili Vijaya Bhaskar
Publicado: (2014)

Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy
por: Aeberli, Daniel, et al.
Publicado: (2013)

Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice
por: Essex, Alyson L., et al.
Publicado: (2019)

Invest in adolescents and young people: it pays
por: Chandra-Mouli, Venkatraman, et al.
Publicado: (2013)

Glucocorticoids and breast cancer risk
por: Hirko, Kelly A., et al.
Publicado: (2021)

Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis
por: Fenton, C. G., et al.
Publicado: (2019)

Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysis
por: Shi, Jialing, et al.
Publicado: (2018)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost–benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ)
por: Fusco, Vittorio, et al.
Publicado: (2022)

Subtrochanteric Femoral Insufficiency Fracture in Woman on Bisphosphonate Therapy for Glucocorticoid-Induced Osteoporosis
por: Bush, Lisabeth A., et al.
Publicado: (2016)

Atypical Femur Fractures in Patients Treated with Bisphosphonates: Identification, Management, and Prevention
por: Bubbear, Judith Sarah
Publicado: (2016)

Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
por: Yuan, Chuanjian, et al.
Publicado: (2023)

Overexpression of WNT16 Does Not Prevent Cortical Bone Loss Due to Glucocorticoid Treatment in Mice
por: Alam, Imranul, et al.
Publicado: (2018)

Cell Transitions Contribute to Glucocorticoid-Induced Bone Loss
por: Qiao, Xiaojing, et al.
Publicado: (2023)

Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions
por: Zimmermann, Elizabeth A., et al.
Publicado: (2016)

COVID-19, Mental Health, and Young People’s Engagement
por: El Omrani, Omnia, et al.
Publicado: (2023)

Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice
por: Eekman, Danielle A, et al.
Publicado: (2011)

Effect of recombinant human bone morphogenetic protein-2 on bisphosphonate-treated osteoblasts
por: Kwon, Taek-Kyun, et al.
Publicado: (2014)

Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years
por: Malluche, Hartmut H, et al.
Publicado: (2021)

Histomorphometry of Bone Microarchitecture in Rats Treated with Vitamin D and Bisphosphonate in the Management of Osteoporosis
por: Queiroz Júnior, José Reginaldo Alves de, et al.
Publicado: (2022)

Glucocorticoids in sepsis: dissecting facts from fiction
por: Marik, Paul E
Publicado: (2011)

Glucocorticoids: do we know how they work?
por: Saklatvala, Jeremy
Publicado: (2002)

Is there a role for glucocorticoid receptor beta in asthma?
por: Gagliardo, Rosalia, et al.
Publicado: (2001)

Glucocorticoids save lives in COVID-19 patients
por: Deng, Chu-Xia
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d75230mhnk1u0q2v9i5ammtnb5